Novel anti-cancer drugs -
Telphone : 123456789
Email Address: info@labtechco.com
CONSULTATION
Home
About Us
Leadership
R&D center
Partnerships
Our Product
Features
Approach
Pipeline
Our Science
Mechanism
Publications
News & Media
New updates
Press release
Investors Resources
General Info
Corporate Governance
Financial Statements
Contacts
Toggle menu
News & Media
PRESS RELEASE
Pet Medical Care
Gongwin’s Compassionate treatment
Gongwin-KY Adopted Compassionate Treatme
Gongwin-KY Completed Case Acceptance for
Gongwin-KY’s endeavors in furry baby can
Zhong Nanshan led Gongwin-KY, the pionee
Gongwin-KY joins hands with three major
2019-11-21 Gongwin-KY Aims at Huge Busin...
2019-11-21 Gongwin-KY’s Liver Cancer New.....Read More
2019-4-12 Gongwin Biopharm Joins Hands...
2019-01-21 Gongwin-KY's Lung Cancer New ...
Gongwin-KY’s skin topical series formula...
Gongwin-KY’s liver cancer new drug PTS10...
"Emerging Market stock" Gongwin-KY was a...
Gongwin-KY’s new drug for adenoid cystic...
NEW UPDATES
Companion Animal Treatment Performance C...
Gongwinbiopharm granted for MUMS sponsor...
Canine Melanoma Field Trial Approved by ...
Canine Melanoma Field Trial Approved by ...
PTS302 receives Official Market Approval...
BIO One-on-One Partnering™